These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association of trimethylamine Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309 [TBL] [Abstract][Full Text] [Related]
7. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. Wheeler DC; London GM; Parfrey PS; Block GA; Correa-Rotter R; Dehmel B; Drüeke TB; Floege J; Kubo Y; Mahaffey KW; Goodman WG; Moe SM; Trotman ML; Abdalla S; Chertow GM; Herzog CA; J Am Heart Assoc; 2014 Nov; 3(6):e001363. PubMed ID: 25404192 [TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis. Palmer SC; Mavridis D; Johnson DW; Tonelli M; Ruospo M; Strippoli GFM Am J Kidney Dis; 2020 Sep; 76(3):321-330. PubMed ID: 32475604 [TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163 [TBL] [Abstract][Full Text] [Related]
10. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156 [TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Chertow GM; Correa-Rotter R; Block GA; Drueke TB; Floege J; Goodman WG; Herzog CA; Kubo Y; London GM; Mahaffey KW; Mix TC; Moe SM; Wheeler DC; Parfrey PS Nephrol Dial Transplant; 2012 Jul; 27(7):2872-9. PubMed ID: 22529163 [TBL] [Abstract][Full Text] [Related]